Gainers
- Revlon, Inc. (NYSE:REV) gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.
- Mereo BioPharma Group plc (NASDAQ:MREO) surged 70% to $1.3580. AstraZeneca is rumored to be eyeing take over of Mereo BioPharma Group, according to a report in The Times.
- Sesen Bio, Inc. (NASDAQ:SESN) gained 30% to $0.7700.
- bluebird bio, Inc. (NASDAQ:BLUE) shares jumped 25.3% to $3.83. The FDA's Advisory Committee recently unanimously backed Bluebird bio’s gene therapy for a rare blood disorder.
- Electric Last Mile Solutions, Inc. (NASDAQ:ELMS) jumped 44% to $0.4061 after jumping 100% on Thursday.
- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) gained 21.2% to $4.7250. Rhythm Pharmaceuticals entered into a Revenue Interest Financing Agreement with HealthCare Royalty Partners for a total investment of $100 million. The U.S. Food and Drug Administration (FDA) has approved Rhythm Pharmaceuticals’ supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS).
- PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) gained 21.2% to $0.6280.
- Scholar Rock Holding Corporation (NASDAQ:SRRK) shares gained 20% to $5.83. Scholar Rock reported Phase 2 topaz trial extension data showing 'sizable and sustained motor function improvement at 24 months with apitegromab for non-ambulatory patients with types 2 and 3 spinal muscular atrophy.'
- Seagen Inc. (NASDAQ:SGEN) shares rose 18.5% to $174.00. Merck is eyeing purchase of biotech Seagen, while other unnamed suitors are also eyeing Seagen, the Wall Street Journal said.
- Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) gained 16.5% to $4.0777. Comera was granted U.S. patent titled 'Excipient compounds for protein processing.'
- SoundHound AI, Inc. (NASDAQ:SOUN) jumped 16.1% to $3.10.
- Surrozen, Inc. (NASDAQ:SRZN) gained 15.5% to $2.5650. Surrozen recently initiated dosing in Phase 1 clinical trial of SZN-043 for severe alcoholic hepatitis.
- Sapiens International Corporation N.V. (NASDAQ:SPNS) surged 15.1% to $24.09.
- AeroClean Technologies, Inc. (NASDAQ:AERC) jumped 14.3% to $20.25.
- Allakos Inc. (NASDAQ:ALLK) gained 14.2% to $2.9700.
- Kinnate Biopharma Inc. (NASDAQ:KNTE) rose 14.1% to $9.39.
- Sight Sciences, Inc. (NASDAQ:SGHT) jumped 12.9% to $8.46.
- Calliditas Therapeutics AB (NASDAQ:CALT) rose 8.5% to $17.26.
- Athersys, Inc. (NASDAQ:ATHX) rose 6.6% to $0.3411 after dropping more than 12% on Thursday.
Losers
- Renovare Environmental, Inc (NASDAQ:RENO) dipped 73.5% to $0.0450.
- Addex Therapeutics Ltd (NASDAQ:ADXN) shares fell 55.3% to $1.61 after the company terminated its Phase 2b/3 study of Dipraglurant for dyskinesia associated with Parkinson's disease due to slow recruitment. The company suspended its guidance amid the termination.
- ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 51.1% to $1.4899 after the company priced a $6 million offering.
- Sidus Space, Inc. (NASDAQ:SIDU) fell 21.7% to $5.97.
- Advent Technologies Holdings, Inc. (NASDAQ:ADN) dipped 20% to $3.1601. Advent Technologies recently announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.
- Neptune Wellness Solutions Inc. (NASDAQ:NEPT) fell 19.5% to $2.19. Neptune Wellness appointed Raymond Silcock as Chief Financial Officer.
- Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 19.1% to $0.5001. Acorda Therapeutics shares jumped around 55% on Thursday after the company announced Esteve Pharmaceuticals GmbH launched INBRIJA in Germany.
- GlucoTrack, Inc. (NASDAQ:GCTK) declined 15.3% to $2.00.
- Hillstream BioPharma, Inc. (NASDAQ:HILS) dropped 14.4% to $0.78.
- Alvotech Ordinary Shares (NASDAQ:ALVO) fell 13.4% to $9.78.
- Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) declined 12.2% to $10.13.
- Heart Test Laboratories, Inc. (NASDAQ:HSCS) dropped 12% to $2.13. Heart Test Laboratories announced pricing of its IPO of 1.5 million units at a price of $4.25 per unit.
- Dream Finders Homes, Inc. (NASDAQ:DFH) dipped 10.3% to $10.60. B of A Securities downgraded Dream Finders Homes from Neutral to Underperform and lowered the price target from $18 to $10.5.
- Vivakor, Inc. (NASDAQ:VIVK) fell 8.8% to $2.27. Vivakor shares jumped 40% on Thursday after the company announced it signed a definitive agreement to acquire Silver Fuels Delhi and White Claw Colorado City.
